Insights & Events

Extraordinarily Knowledgeable

FDA Labeling Preemption Precludes Plaintiffs’ Failure-to-Warn Claims in MDL Targeting Vaccine

publication | March 24, 2025

In this Legal Opinion Letter for Washington Legal Foundation, Hollingsworth LLP partners Robert E. Johnston and Shannon N. Proctor explain how a federal trial court correctly concluded that an HPV vaccine manufacturer lacked authority under the federal “changes being effected” regulation to unilaterally add safety information and thus could not be held liable under state common law.